Clinical Trial Update: Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload [Phase 2]

View source ↗

Summary

Phase 2 trial comparing deferasirox to deferoxamine for treating cardiac iron overload in patients with transfusional iron overload. The study has been complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Iron Overload
• Transfusional Hemosiderosis
• Transfusional Iron Overload

Drugs mentioned

• Desferal (Deferoxamine Mesylate)
• Exjade (deferasirox)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Transfusional Iron Overload, Transfusional Hemosiderosis | Phase 2 | Status: COMPLETED | Results posted: 2014-08-27